Methodology

All entries for: Ajax Therapeutics Inc.

July 8, 2025

Ajax Therapeutics Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of myelofibrosis

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top